Follow
James Root
James Root
Verified email at astrazeneca.com
Title
Cited by
Cited by
Year
In vitro and in vivo characterization of PF‐04418948, a novel, potent and selective prostaglandin EP2 receptor antagonist
KJ Af Forselles, J Root, T Clarke, D Davey, K Aughton, K Dack, N Pullen
British journal of pharmacology 164 (7), 1847-1856, 2011
1612011
Linking increased airway hydration, ciliary beating, and mucociliary clearance through ENaC inhibition
ABM Åstrand, M Hemmerling, J Root, C Wingren, J Pesic, E Johansson, ...
American Journal of Physiology-Lung Cellular and Molecular Physiology 308 (1 …, 2015
782015
Dipeptidyl peptidase 1 inhibitor AZD7986 induces a sustained, exposure‐dependent reduction in neutrophil elastase activity in healthy subjects
R Palmér, J Mäenpää, A Jauhiainen, B Larsson, J Mo, M Russell, J Root, ...
Clinical Pharmacology & Therapeutics 104 (6), 1155-1164, 2018
672018
Discovery of second generation reversible covalent DPP1 inhibitors leading to an oxazepane amidoacetonitrile based clinical candidate (AZD7986)
K Doyle, H Lönn, H Käck, A Van de Poël, S Swallow, P Gardiner, ...
Journal of Medicinal Chemistry 59 (20), 9457-9472, 2016
622016
Attached stratified mucus separates bacteria from the epithelial cells in COPD lungs
JA Fernández-Blanco, D Fakih, L Arike, AM Rodríguez-Piñeiro, ...
JCI insight 3 (17), 2018
442018
Multiparameter Optimization in CNS Drug Discovery: Design of Pyrimido[4,5-d]azepines as Potent 5-Hydroxytryptamine 2C (5-HT2C) Receptor Agonists with Exquisite Functional …
RI Storer, PE Brennan, AD Brown, PJ Bungay, KM Conlon, MS Corbett, ...
Journal of Medicinal Chemistry 57 (12), 5258-5269, 2014
362014
Targets of neutrophil influx and weaponry: therapeutic opportunities for chronic obstructive airway disease
CK Mårdh, J Root, M Uddin, K Stenvall, A Malmgren, K Karabelas, ...
Journal of immunology research 2017, 2017
282017
Prostanoid receptors mediating contraction in rat, macaque and human bladder smooth muscle in vitro
JA Root, DA Davey, KJA Forselles
European Journal of Pharmacology 769, 274-279, 2015
182015
Pyrimido [4, 5-d] azepines as potent and selective 5-HT2C receptor agonists: Design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence
MD Andrews, PV Fish, J Blagg, TK Brabham, PE Brennan, A Bridgeland, ...
Bioorganic & medicinal chemistry letters 21 (9), 2715-2720, 2011
142011
Target engagement confirmed in man with a dipeptidyl peptidase 1 inhibitor
K Stenvall, J Mo, M Russel, P Gardiner, R Palmer, A Jauhiainen, ...
European Respiratory Journal 50 (suppl 61), 2017
52017
Safety of medicine and the use of animals in research
K Archibald, AD Baxter, K BeruBe, D Bunton, M Clotworthy, B Coleman, ...
The Lancet 378 (9802), e2, 2011
52011
Opioid receptor characterisation of neuronally stimulated isolated human vas deferens
J Root, AMLC Wakenhut, H Siggins, S Katugampola, C Napier
Naunyn-Schmiedeberg's archives of pharmacology 385, 1049-1052, 2012
32012
Effect of alosetron and tegaserod at the 5-HT2B receptor in human colon
RA Borman, J Wade, J Root, D Riddy, K Clark, B Coleman
Gastroenterology 128 (4), A271-A271, 2005
32005
Preclinical evaluation of the epithelial sodium channel inhibitor AZD5634 and implications on human translation
A Åstrand, EF Libby, RJ Shei, JEP Lever, N Kaza, AT Adewale, E Boitet, ...
American Journal of Physiology-Lung Cellular and Molecular Physiology 323 (5 …, 2022
22022
COPD lungs show an attached stratified mucus layer resembling the protective colonic mucus
JA Fernández-Blanco, L Arike, A Ermund, D Fakih, AM Rodríguez-Piñeiro, ...
BioRxiv, 205948, 2017
12017
Inhibition of neutrophil serine protease activation with the reversible DPP1 inhibitor AZD7986
J Root, J Bernstrom, S Clifton, G Dahl, K Doyle, P Gardiner, ...
C70. THE NEXT NEW THERAPEUTIC TARGET? TRANSLATIONAL STUDIES OF COPD …, 2016
12016
A MODEL OF CHRONIC LUNG DISEASE AS IN CF SHOWS ATTACHED STRATIFIED MUCUS THAT RESEMBLES THE PROTECTIVE COLON MUCUS
J Fernandez-Blanco, L Arike, A Ermund, D Fakih, AM Rodriguez-Pineiro, ...
PEDIATRIC PULMONOLOGY 52, S250-S250, 2017
2017
Intranasal Elastase Induces Mucus Accumulation And Alterations In Lung Mucus Proteome In Mice
JA Fernandez-Blanco, A Ermund, AM Rodriguez-Pineiro, J Root, ...
A40. EPITHELIAL REGULATION OF INFLAMMATION, A1463-A1463, 2016
2016
C70 THE NEXT NEW THERAPEUTIC TARGET? TRANSLATIONAL STUDIES OF COPD THERAPIES: Inhibition Of Neutrophil Serine Protease Activation With The Reversible Dpp1 Inhibitor Azd7986
J Root, J Bernstrom, S Clifton, G Dahl, K Doyle, P Gardiner, ...
American Journal of Respiratory and Critical Care Medicine 193, 1, 2016
2016
A40 EPITHELIAL REGULATION OF INFLAMMATION: Intranasal Elastase Induces Mucus Accumulation And Alterations In Lung Mucus Proteome In Mice
J Fernandez-Blanco, A Ermund, A Rodriguez-Pineiro, J Root, C McCrae, ...
American Journal of Respiratory and Critical Care Medicine 193, 1, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–20